Abhidha Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -24.05%
- Profit Growth 214.22%
- Ebitda 90.41%
- Net Worth 67.58%
- Total Assets 37.84%
About Abhidha Pharma
Abhidha Pharma Private Limited (APPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 27 October 2017 (Seven years and three months 6 days old ). Its registered office is in Jabalpur, Madhya Pradesh, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Kanojiya and Rajendra Chouhan serve as directors at the Company.
Company Details
-
Location
Jabalpur, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MP2017PTC044410
-
Company No.
044410
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Oct 2017
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Abhidha Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Kanojiya
|
Managing Director | 27-Oct-2017 | Current |
|
Rajendra Chouhan
|
Managing Director | 27-Oct-2017 | Current |
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Abhidha Pharma.
Abhidha Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 24.05% decrease. The company also saw a substantial improvement in profitability, with a 214.22% increase in profit. The company's net worth Soared by an impressive increase of 67.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abhidha Pharma?
Unlock access to Abhidha Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Abhidha Pharma?
Unlock and access historical data on people associated with Abhidha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abhidha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abhidha Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
